Skip to main content
. 2018 Mar 19;319(14):1473–1484. doi: 10.1001/jama.2018.2757

Figure 3. Association of LAMA Add-on Therapy With FEV1 Trough and Rescue Medication Use.

Figure 3.

FEV1 indicates forced expiratory volume in the first second; ICS, inhaled corticosteroid; LABA, long-acting β-agonist; LAMA, long-acting muscarinic antagonist; MD, mean difference. Size of the data markers indicate the weight of the study. For more information, see Figure 2 footnotes.